We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Managing your lung program can seem daunting, whether you’re getting going, growing, or managing workflow. We’ve curated resources for you.
Riverain Technologies takes great lengths to remain active and vital in our industry. We hope we can meet you soon at a future event and remain connected through our latest posts, news releases, and social media.
Join us for the 108th Scientific Assembly and Annual Meeting – RSNA 2022
Venue: McCormick Place, South Hall, Booth # 3935
Riverain’s ClearRead solutions eliminate obstructions that often stand in the way of accurately and efficiently detecting disease in thoracic (lung) CT and XR images. Come see how!
Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
